Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 07, 2020

HIPEC With Cisplatin, Mitomycin, and Paclitaxel for Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

Annals of Surgical Oncology

 

Additional Info

Annals of Surgical Oncology
Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin, Mitomycin, and Paclitaxel in Patients With Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology
Ann. Surg. Oncol 2020 Jan 23;[EPub Ahead of Print], M Blum Murphy, N Ikoma, X Wang, J Estrella, S Roy-Chowdhuri, P Das, BD Minsky, S Song, P Mansfield, J Ajani, B Badgwell

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading